Pioglitazone
- Product NDC
- 53002-2755
- 11-digit product format
- 530022755
- Labeler code
- 53002
- Product ID
- 53002-2755_ce3db755-75a4-4150-8459-d9977d574564
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Pioglitazone
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA077210
- Marketing category
- ANDA
- Marketing start
- 2015-02-04
- Marketing end
- 0000-00-00
- Substance
- PIOGLITAZONE HYDROCHLORIDE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Peroxisome Proliferator-activated Receptor Activity [MoA],PPAR alpha [CS],PPAR gamma [CS],Thiazolidinedione [EPC],Thiazolidinediones [CS],Peroxisome Proliferator Receptor alpha Agonist [EPC],Peroxisome Proliferator Receptor gamma Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 53002-2755-3 | 53002275503 | 30 TABLET in 1 BOTTLE (53002-2755-3) | 30 tablet | 2020-01-01 | 0000-00-00 | No | No | Current |
| 53002-2755-9 | 53002275509 | 90 TABLET in 1 BOTTLE (53002-2755-9) | 90 tablet | 2020-01-01 | 0000-00-00 | No | No | Current |